Lancet. 2012 May 12;379(9828):1835-46. doi: 10.1016/S0140-6736(11)61904-1. Epub 2012 Apr 10.
PMID:22494827
Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Ke CH, Sio KM, Wu CH, Xia YY, Lee JJ, Hu CH, Liu CC, Lu CL, Cheng CL, Lin KH, Tomiyasu H, Wang YS, Lin CS.
J Vet Intern Med. 2023 Nov-Dec;37(6):2391-2401. doi: 10.1111/jvim.16898. Epub 2023 Oct 14.
PMID:37837297
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
de Maat MP, Nieuwenhuizen W, Knot EA, van Buuren HR, Swart GR.
Thromb Res. 1995 May 15;78(4):353-62. doi: 10.1016/0049-3848(95)91463-u.
PMID:7631315
Exciting Performance of Plasma Fibrinogen in Periprosthetic Joint Infection Diagnosis.
Huang JC, Chen X, Qiang S, Zheng WD, Zheng J, Jin Y.
Orthop Surg. 2021 May;13(3):812-816. doi: 10.1111/os.12964. Epub 2021 Mar 15.
PMID:33719200
[Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
Rinsho Byori. 2001 Mar;49(3):283-9.
PMID:11307330
[Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K, Wada H, Abe Y, Tomatsu H, Nishioka J, Nobori T.
Rinsho Byori. 2003 Apr;51(4):295-9.
PMID:12747249
Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
Chek JB, Panchenko NI.
East Afr Med J. 2000 Apr;77(4):217-20.
PMID:12858907
D-dimers (DD) in CVST.
Wang HF, Pu CQ, Yin X, Tian CL, Chen T, Guo JH, Shi Q.